Basel: Roche, announced that the U.S. Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for an ...

Edesa Biotech, Inc. , a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the three ...

The global surface plasmon resonance (SPR) system market is on a steady growth trajectory, with a projected valuation of USD ...

The Department of Biochemistry of AIIMS Bhopal successfully concluded the XIII Annual International Conference of the Indian Academy of Biomedical Sciences (IABSCON 2025), held from 11-13, 2025. The c ...

Some 17 companies successfully raised growth capital totalling €503m. This equates to a 254% increase in value terms compared ...

In December 2024, the Company announced a strategic restructuring of its business operations, including the potential divestiture of its DNA Tagging and Security Products and Services ("DNA Tagging") ...

Fresh off winning a Nobel Prize last year, and previously tackling antibodies and peptides, the University of Washington’s ...

Envisagenics, an AI-driven biotechnology company revolutionizing RNA splicing research and therapeutics, has appointed Sudhir Rao, M.S., MBA as Chief Business Officer (CBO) to expand and strengthen ...

COEP Venture Group aims to identify, invest in, and support high-potential startups shaping the future of automation, intelligent systems, and AI-driven enterprise solutions. By providing capital, ...

Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.

BOSTON, Feb. 13, 2025 /PRNewswire/ -- Health industry leaders and advocates come together for The Boston Globe's Rare Disease Summit, featuring powerful conversations with the rare disease community ...

Alfa Chemistry has made a remarkable stride in the field of synthetic biology with the recent renewal of its oligonucleotide series products. This updated lineup includes a range of advanced ...